Heartworm is the diagnosis dog owners dread twice: once for the dog, and once for the bill. A full course of treatment at a private veterinary practice commonly runs $1,000 to $3,000 or more, and it stretches across months of crate rest, antibiotics and painful injections into the muscles along a dog's spine.
So a study published on August 20, 2026 in Parasites & Vectors is worth paying attention to. Researchers reviewed 1,246 shelter dogs treated for heartworm at Miami-Dade Animal Services between 2014 and 2024 and found that a shorter, cheaper version of the standard protocol cleared the infection in 96% of dogs — statistically indistinguishable from the longer regimen most veterinarians use today.
That is not permission to skip your vet's advice. But it is a meaningful development for the tens of thousands of dogs each year whose owners are told the price and simply cannot pay it. Here's what the research actually says, and what it changes for you.
What the study found
Heartworm's adult worms are killed with an injectable drug called melarsomine. The American Heartworm Society (AHS) currently recommends a three-dose protocol: 30 days of the antibiotic doxycycline plus a monthly preventive, then one melarsomine injection on Day 60, followed by two more on Days 90 and 91.
An older two-dose protocol — two injections 24 hours apart, skipping the standalone first shot — is faster and cheaper, but it was last seriously studied before doxycycline and monthly preventives became standard companions to treatment. The Miami-Dade team asked the obvious question: now that those adjuncts are routine, does the shorter protocol hold up?
Across 889 dogs on the two-dose protocol and 357 on the three-dose protocol, all with class 1 or class 2 (mild to moderate) disease:
- Follow-up tests were negative in 242 of 252 two-dose dogs (96.0%) versus 24 of 24 three-dose dogs (100%) — not a statistically significant difference.
- All-cause mortality was 0.8% in the two-dose group versus 2.6% in the three-dose group — also not significant.
- Mild complications were more common in the two-dose group (7.4% vs. 3.6%), while severe complications were more common in the three-dose group (1.4% vs. 0.3%).
- Dogs whose preventive at intake was sustained-release moxidectin had zero treatment failures (0 of 33), compared with failures in dogs started on ivermectin (2 of 65) or milbemycin (2 of 35).
The authors' conclusion is deliberately careful: two-dose melarsomine with doxycycline and a macrocyclic lactone is "a potential alternative" for mild-to-moderate disease, and moxidectin "may be the preferred" preventive alongside it.
The caveats that matter
This was a retrospective review of shelter records, not a randomized trial. Dogs were not assigned to groups at random, follow-up testing was available for only a fraction of them (252 of 889 in the two-dose group), and every dog had early-stage disease. The AHS guidelines still state plainly that the three-dose regimen "is more effective at eliminating adult worms." Nothing here overturns that for a dog with advanced heartworm disease.
What the study does is give veterinarians better evidence for a conversation many are already having: what to do when the choice isn't between two protocols, but between one protocol and none at all.
Why this is landing now
Heartworm is not receding. The Companion Animal Parasite Council's 2026 Pet Parasite Forecast, released in March, projects continued northward spread along the Mississippi River corridor and up the Atlantic coast, putting much of the central and eastern U.S. — "from Kansas to Maryland" — at rising risk. CAPC also flagged persistent pockets of elevated risk in parts of the Mountain West and Northern California, regions long treated as non-endemic.
The drivers are the Asian tiger mosquito and yellow fever mosquito expanding their ranges, warmer and longer transmission seasons, the movement of infected dogs between states, and inconsistent preventive use. CAPC builds these forecasts from more than 10 million diagnostic test results per disease per year, and says its predictions have historically been over 94% accurate.
Translation for owners: "we don't have heartworm here" is a sentence with a shrinking number of accurate places to be said.
What to do if your dog just tested positive
Follow your veterinarian's plan. But know the shape of it in advance, because the hardest part is the part owners are responsible for.
1. Confirm the diagnosis
AHS recommends confirming a positive antigen test with a second, different test before starting treatment. The protocol is expensive and demanding enough that certainty comes first.
2. Restrict exercise — starting immediately
This is the single most important thing you control. Exertion raises heart rate and drives dying worms into the lungs, which is how treatment kills dogs. AHS guidance is strict confinement from diagnosis through six to eight weeks after the final melarsomine injection, with leashed potty breaks only. Not "shorter walks." Leashed, and that's it.
3. Expect a staged, months-long protocol
Stabilization if needed, then doxycycline for 30 days to kill Wolbachia — the bacteria living inside heartworms that amplify inflammation when worms die — plus a monthly preventive, then the injection series, then a recheck test roughly six months after treatment ends.
4. Ask about cost tiers before you panic
Published estimates from nonprofit clinics show a wide spread: subsidized programs may treat owned dogs for roughly $225 to $2,000, tiered by weight, while private practice commonly runs $1,000 to $3,000+. Emergency care for advanced disease climbs higher; caval syndrome surgery alone can run $3,000 to $6,000. Ask about payment plans, veterinary financing, and whether your local humane society runs a subsidized heartworm program — many do, often with waitlists worth joining early. And ask whether the two-dose protocol is appropriate for your dog's stage.
5. Don't self-prescribe "slow kill"
Giving preventives alone and hoping the worms die off is not a budget version of treatment. AHS calls it a salvage procedure, not a treatment of choice: it can take a year or more, worm death is unpredictable, and the damage to pulmonary blood vessels during that wait can be permanent. If cost is the barrier, say so out loud to your vet — that's a conversation with options in it.
The math that never changes: prevention
A year of monthly prevention costs a small fraction of one treatment course. Roughly $150 to $350 a year for most dogs, against a four-figure bill and months of crate rest. Every FDA-approved preventive is prescription-only, which means an annual test and a vet visit are part of the deal.
Do:
- Give preventive year-round, not seasonally. AHS and the FDA both recommend it — partly because mosquito seasons have stretched, and partly because continuous dosing is a safety net when you inevitably forget one.
- Set a recurring phone alarm for dose day. Missed and late doses are the most common failure point; efficacy against later larval stages drops off past the 30-day interval.
- Test annually, even on year-round prevention.
- Add mosquito control. AHS notes that an EPA-registered repellent/ectoparasiticide improved protection in lab studies involving resistant heartworm isolates. Dump standing water in the yard while you're at it.
- Ask about your product specifically if you live in the Lower Mississippi Delta, where ML-resistant heartworm strains are documented. A May 2026 study in Parasites & Vectors testing two moxidectin combination products against a resistant isolate found 99.5% and 98.1% efficacy respectively — high, but with worms recovered from 25% and 75% of treated dogs. Dose level matters.
Don't:
- Skip winter months because it's cold where you live.
- Double up to "catch up" after a missed dose without asking your vet.
- Give ivermectin-based products to a herding breed without MDR1 (ABCB1) testing — Collies and related breeds can be unusually sensitive.
- Assume a dog adopted from out of state was tested. Ask, and retest six months after adoption.
The bottom line
One retrospective study does not rewrite the guidelines, and your veterinarian is still the person who should decide which protocol fits your dog's stage of disease. But the direction of the evidence is encouraging: for mild and moderate cases, there may be a shorter, less expensive path that doesn't trade away outcomes — and that matters enormously in a country where cost, not medicine, is what keeps a lot of dogs from getting treated.
The version of this story you'd rather live is the boring one. A pill on the first of the month, a test once a year, and a diagnosis you never get.
Sidewalk Dog helps dog owners find the best places to go and the best information to keep their dogs healthy. Browse our city guides for dog-friendly spots near you, and find more health explainers at sidewalkdog.com.
